Documents

Q1 2018 SALES: €87.6M LIKE-FOR-LIKE GROWTH UP 5.6%, 0.4% AS REPORTED GROWTH OF ESSENTIALS PRODUCTS: UP 6.8% AS REPORTED

Vetoquinol posted Q1 2018 consolidated sales of €87.6 million, up 5.6% like for like and 0.4% as reported, compared to the same period last year. Negative currency impacts of 5.2% were mainly related to the US and Canadian dollars and the Indian rupee. 

Document type:
  • Public releases
Page count:
2 page(s)
Basket
Empty basket

INVESTORS CORNER

Vetoquinol has been listed on the Euronext Paris stock market since November 16th.

Consult the documents of the Meeting

Contact

Composition of the bodies of Corporate Management and Governance

Financial information and key figures: annual, half-year and by sector key figures